E. De Brauwer, H.W. Van Landuyt, B. Gordts, J.R. Boelaert 

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

Laboratory diagnosis and biosafety issues of biological warfare agents
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
Staphylococcus lugdunensis vertebral osteomyelitis
Interpretive criteria of ceftibuten disk diffusion susceptibility tests according to the DIN method  Kleinkauf N. , Rodloff A.C.   Clinical Microbiology.
Gut bacterial microbiota and obesity
I.J. Schalk  Clinical Microbiology and Infection 
Approach to diagnosis of infective endocarditis
Herpes zoster in non-hospitalized children
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
J.-P. Van geertruyden  Clinical Microbiology and Infection 
C. Loupa, D. Voyatzoglou, H. Papadaki, G. Kouppari, G. Saroglou 
E. Cambau, M. Drancourt  Clinical Microbiology and Infection 
Louis Pasteur, from crystals of life to vaccination
How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development  R. Bax  Clinical Microbiology.
An eye-catching acanthocephalan
Should standardized susceptibility testing for microbial biofilms be introduced in clinical practice?  T. Coenye, D. Goeres, F. Van Bambeke, T. Bjarnsholt 
Pyogenic hepatic abscess: clues for diagnosis in the emergency room
Clinical Microbiology and Infection
How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach  D. Guillemot  Clinical Microbiology.
In vitro activity, postantibiotic effect and human monocyte activity of grepafloxacin against Legionella species  Jacques Dubois, Claude St-Pierre  Clinical.
Holt Hanne M. , Søgaard Per , Gahrn-Hansen Bente  
Structure of grepafloxacin relative to activity and safety profile
Vector control: a cornerstone in the malaria elimination campaign
J.P. Donnelly, B.E. De Pauw  Clinical Microbiology and Infection 
L. Gatta, C. Ricci, A. Tampieri, D. Vaira 
C-3′Quaternary Ammonium Cephems, a New Wave of Cephalosporins
Oral versus intravenous therapy in the treatment of systemic mycosis
Training for the infectious diseases speciality in Norway
F. Grill, P. Muñoz, R. Jofre, E. Bouza 
B. Gordts  Clinical Microbiology and Infection 
Laboratory diagnosis and biosafety issues of biological warfare agents
In vitro selection of antibiotic resistance in Pseudomonas aeruginosa
Metagenomics and probiotics
Effect of antioxidants on the immune response of Helicobacter pylori
Laboratory diagnosis of Clostridium difficile disease
Recent developments in staphylococcal scalded skin syndrome
S8 – S47 and O50 – O440 Clinical Microbiology and Infection
G.R. Davies  Clinical Microbiology and Infection 
A. Bryskier  Clinical Microbiology and Infection 
Pathogenesis of catheter-related infections: lessons for new designs
Systematic review of antibiotic consumption in acute care hospitals
Community-acquired pneumonia: epidemiologic and clinical consideration
Abstracts cont. Clinical Microbiology and Infection
Training in infectious diseases and tropical medicine in Britain
J. R. Blanco, C. Gutierrez, M. Zabalza, J. Salcedo, I. Erdozain, J. A
Fibronectin concentrations in catheter sepsis
Clinical infection services—the Leiden experience
Training in infectious diseases—looking to the future
Clinical Microbiology and Infection
W. Eugene Sanders, Christine C. Sanders 
Overview of cefixime use in community-acquired infections
K. Kaier, N.T. Mutters, U. Frank  Clinical Microbiology and Infection 
The atypical pneumonias: clinical diagnosis and importance
Facilitating learning and change in physicians: Implications for a system of continuing medical education in Europe  Robert D. Fox  Clinical Microbiology.
Abstracts Clinical Microbiology and Infection
Virology: a scientific discipline facing new challenges
Modelling during an emergency: the 2009 H1N1 influenza pandemic
New oral cephalosporins in pediatric community-acquired infections
Influence of climate change on the incidence and impact of arenavirus diseases: a speculative assessment  J.C. Clegg  Clinical Microbiology and Infection 
Carratalà J.   Clinical Microbiology and Infection 
N. Markeas, G. Stamos, I. Paraskakis, A. Giokas, G. Pistevos 
J.L. Balcázar  Clinical Microbiology and Infection 
Clinical microbiological case: thermointolerant microorganism growth in blood cultures and catheter tip  M. Blasco-Navalpotro, M. Jordán, J.J. Camarena,
Typing of Clostridium difficile
J.A. Pérez-Molina, F. Fernández  Clinical Microbiology and Infection 
Impact of antibiotic restrictions: the patient's perspective
Localized Mycobacterium avium complex infection in a patient on HAART
CMI readers' survey Clinical Microbiology and Infection
The future of diagnostic bacteriology
Presentation transcript:

In-vitro acquisition of iron from the iron-desferrioxamine complex by Aeromonas hydrophila  E. De Brauwer, H.W. Van Landuyt, B. Gordts, J.R. Boelaert  Clinical Microbiology and Infection  Volume 1, Issue 4, Pages 273-274 (June 1996) DOI: 10.1016/S1198-743X(15)60287-7 Copyright © 1996 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 1 Effect of Fe.DFO on the growth of Aeromonas hydrophila on an iron-restricted plate. Filter paper disks contained 20 μl of 1 (a), 10 (b), 50 (c) and 100 (d) μM Fe.DFO. The greater the concentration, the greater the diameter of the growth of Aeromonas hydrophila around the disks. Clinical Microbiology and Infection 1996 1, 273-274DOI: (10.1016/S1198-743X(15)60287-7) Copyright © 1996 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 2 After 48 h of incubation, no growth of Aeromonas hydrophila was visible around the disk containing 50 μM iron complex of 1,2-dimethyl-3-hydroxy-4-pyridone [Fe.(L1)3] (a), as contrasted with the growth-enhancing effect on Aeromonas hydrophila visible around the disk containing 100 μM Fe.DFO (b). Clinical Microbiology and Infection 1996 1, 273-274DOI: (10.1016/S1198-743X(15)60287-7) Copyright © 1996 European Society of Clinical Infectious Diseases Terms and Conditions